Duopharma Q3 financial results improve

Year-to-date, Duopharma’s net profit rose 17.8% to RM49.97mil from RM42.42mil in the nine months to September 2020, while revenue grew 13.3% to RM493.73mil from RM435.82mil previously.

PETALING JAYA: Duopharma Biotech Bhd’s net profit rose 20% to RM16.93mil for the third quarter ended Sept 30, 2021 (Q3’21) from RM14.13mil in Q3’20 on higher revenue and lower expenditures.

The company’s revenue rose 28.5% to RM171.84mil in Q3’21 from RM133.77mil previously.